Synthesis, physicochemical and immunological properties of oxidized inulin-l-asparaginase bioconjugate

Journal of Biotechnology

Volumn 141, Issue 3-4, 2009, Pages 189-195

  Tabandeh, Mohammad Reza ^a,b   Aminlari, Mahmood ^a  

^a SHIRAZ UNIVERSITY   (Iran)

^b SHAHID CHAMRAN UNIVERSITY OF AHVAZ   (Iran)

Author keywords

Immunogenecity; l Asparaginase; Modification; Oxidized inulin; Physicochemical properties

Indexed keywords

IMMUNOGENECITY; L-ASPARAGINASE; MODIFICATION; OXIDIZED INULIN; PHYSICOCHEMICAL PROPERTIES;

REUSABILITY; SYNTHESIS (CHEMICAL);

ENZYMES;

ASPARAGINASE; GLYCOCONJUGATE; IMMUNOGLOBULIN G; INULIN; INULIN ASPARGINASE CONJUGATE; PERIODATE; TRYPSIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANTIBODY BLOOD LEVEL; ANTIBODY TITER; ARTICLE; BIOCHEMICAL COMPOSITION; CONJUGATION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME METABOLISM; ENZYME MODIFICATION; ENZYME PURIFICATION; ENZYME STABILITY; ENZYME SYNTHESIS; FREEZE DRYING; FREEZE THAWING; HALF LIFE TIME; IMMUNOGENICITY; MALE; NONHUMAN; PH; PRIORITY JOURNAL; PROTEIN SYNTHESIS; RABBIT; THERMOSTABILITY;

ANIMALS; ANTINEOPLASTIC AGENTS; ASPARAGINASE; ENZYME STABILITY; FREEZE DRYING; GLYCOPROTEINS; HYDROGEN-ION CONCENTRATION; IMMUNOGLOBULIN G; INULIN; KINETICS; LINEAR MODELS; MALE; OXIDATION-REDUCTION; PROTEIN BINDING; RABBITS; TEMPERATURE;

ORYCTOLAGUS CUNICULUS;

EID: 67349223879     PISSN: 01681656     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jbiotec.2009.03.020     Document Type: Article

References (39)

1. Amiri S., Ramezani R., and Aminlari M. Antibacterial activity of dextran-conjugated lysozyme against Escherichia coli and Staphylococcus aureus in cheese curd. J. Food. Prot. 71 (2008) 411-415
2. Asselin B.L., Ryan D., Frantz C.N., Bernal S.D., Leavitt P., Golbey R.D., Krakoff I.H., Karnofsky D.A., Burchen-Sallan S.E., and Cohen H.J. In vitro and in vivo killing of acute lymphoblastic leukemia cells by l-asparaginase. Cancer Res. 49 (1989) 4363-4368
3. Asselin B.L., Whitin J.C., Coppola D.J., Rupp I.P., Sallan S.E., and Cohen H.J. Comparative pharmacokinetic studies of three asparaginase preparations. J. Clin. Oncol. 11 (1993) 1780-1786
4. Boos J. Pharmacokinetics and drug monitoring of l-asparaginase treatment. Int. J. Clin. Pharm. Ther. 35 (1997) 96-98
5. Carabin I.G., and Flamm W.G. Evaluation of safety of inulin and oligofructose as dietary fiber. Regul. Toxicol. Pharmacol. 30 (1999) 268-282
6. Clementi A. La desemidation enzymatique de l-asparagine chez les differentes especes animales et la signification physiologique de sa presence dans l organisma. Arch. Int. Physiol. 19 (1922) 369-376
7. Diftis N., and Kiosseoglou V. Improvement of emulsifying properties of soybean protein isolate by conjugating with carboxymethyl cellulose. Food Chem. 81 (2003) 1-6
8. Dubois M., Gilles K.A., Hamilton K., Rebers A.P., and Smith F. Colorimetric method for determination of sugars and related substances. Anal. Chem. 28 (1956) 350-356
9. Fu C., Nandy P., Danenberg P., and Avramis V.L. l-Asparaginase (ASNase) induced cytotoxicity depend on p53 status of the cells. Proc. Am. Assoc. Cancer Res. 39 (1998) 602-630
10. Habeeb A.F.S.A. Determination of free amino group in proteins by trinitrobenzenesulfonic acid. Anal. Biochem. 11 (1996) 328-336
11. Karsakevich A.S., Dauvarte A.Z.H., Zvirgzda I.K., Lebedeva L.V., and Vina I.A. Effective complexes of the antileukemic enzyme l-asparaginase and dextran sulphate. Jpn. J. Cancer Res. 77 12 (1986) 264-1270
12. Kaur N., and Gupt A.K. Applications of inulin and oligofructose in health and nutrition. J. Biosci. 27 (2002) 703-714
13. Kidd G. Regression of transplanted lymphomas induced in vivo by means of normal guinea pig serum. I. Course of transplanted cancers of various kinds in mice and rats given guinea pig serum, horse serum or rabbit serum. J. Exp. Med. 98 (1953) 565-582
14. Killander D., Dohlwitz A., Engstedt L., Franzen S., Gahrton G., Gullbring B., Holm G., Holmgren A., Hoglund S., Killander A., Lockner D., Mellstedt H., Moe P.J., Palmblad J., Reizenstein P., Skarberg K.-O., Swedberg B., Uden A.M., Wadman B., Wide L., and Ahstrom L. Hyper-sensitivity reactions and antibody formation during l-asparaginase treatment of children and adults with acute leukemia. Cancer 37 (1976) 220-228
15. Kotzia G.A., and Labrou N.E. Cloning, expression and characterisation of Erwinia carotovora l-asparaginase. J. Biotech. 119 (2005) 309-323
16. Kotzia G.A., and Labrou N.E. l-Asparaginase from Erwinia Chrysanthemi 3937: cloning, expression and characterization. J. Biotech. 127 20 (2007) 657-669
17. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227 (1970) 680-685
18. Lowry O.H., Rosebrough N.J., Farr A.L., and Randall R.J. Protein measurement with the folin phenol reagent. J. Biol. Chem. 193 (1951) 265-275
19. Marlborough D.I., Miller D.S., and Cammack K.A. Comparative study on conformational stability and subunit interactions of two bacterial asparaginases. Biochim. Biophys. Acta 386 (1975) 576-589
20. Mashburn L.T., and Wriston J.C. Tumor inhibitory effect of lasparaginase. Biochem. Biophys. Res. Commun. 12 (1963) 50-56
21. Mathe G., Amiel J.L., Clarysse A., Hayat M., and Schwarzenberg L. The place of the l-asparaginase in the treatment of acute leukemias. Rec. Res. Cancer 33 (1970) 278-287
22. Miller M., Mohana Rao J.K., Wlodawer A., and Gribskov M.R. Crystal structure of Erwinia chrysanthemi l-asparaginase with bound l-aspartate. FEBS Lett. 328 (1993) 275-279
23. Peterson R.G., Hanschumacher R.E., and Mitchell M.S. Immunological responses to l-asparaginase. J. Clin. Invest. 50 (1971) 1080-1090
24. Poznansky M.J., Shandling M., Salkie M.A., Lau A., and Elliott J. Advantages in the use of L-asparaginase albumin polymer as an antitumor agent. Cancer Res. 42 3 (1982) 1020-1025
25. Qian G., Zjjou J., Jianbiao W.D., and He B. The chemical modification of E. coli l-asparaginase by N,O-carboxymethyl chitosan. Artificial cells blood substitutes and immobilization. Biotechnology 24 (1996) 567-577
26. Rizzari C., Citterio M., Zucchetti M., Zucchetti M., Conter V., Chiesa R., Colombini A., Malguzzi S., Silvestri D., and D'Incalci M. A pharmacological study on pegylated asparaginase used in front-line treatment of children with acute lymphoblastic leukemia. Haematologica 91 (2006) 24-31
27. Saito T., Obata M., Todokoro K., Okubo M., Minowa M., Yamazaki S., Tamaura Y., and Inada Y. Modification of cystein or tryptophan residues in the asparaginase molecule and their role in conformation and antigenecity. FEEBS Lett. 65 (1976) 11-15
28. Scaman C., Nakai S., and Aminlari M. Effect of pH, temperature and sodium bisulfite or cysteine on the level of Maillard-based conjugation of lysozyme with dextran, galactomannan and mannan. Food Chem. 99 (2006) 368-380
29. Shepard D., Donovan M., Raghupathy E., Yeung K.-K., Owen A.J., and Dain J.A. Effect of immobilization on the stability and substrate specificity of α-d-galactosidase isolated from the invertebrate Turbo cornutus. Carbohydr. Res. 118 (1983) 239-245
30. Shimizu T., Kubota M., and Adachi S. Pretreatment of a human T-lymphoblastoid cell line with l-asparaginase reduces etopside-induced DNA strand breakage and cytotoxicity. Int. J. Cancer 50 (1992) 644-648
31. Soares A.L., Guimarães G.M., Polakiewicz B., Pitombo R.N.M., and Abrahão-Neto J. Effects of polyethylene glycol attachment on physicochemical and biological stability of E. coli l-asparaginase. Inter. J. Pharm. 237 (2002) 163-170
32. Stechera A.L., Deusa P.M., Polikarpovb L., and Abrahão-Neto J. Stability of l-asparaginase: an enzyme used in leukemia treatment. Pharm. Act. Help 74 (1999) 1-9
33. Ueno T., Ontawa K., Mitusi K., Kodera Y., Hiroto M., Matsushima A., Inada Y., and Nishimura H. Cell cycle arrest induced by l-asparaginase. Leukemia 11 (1997) 1858-1861
34. Verma N., Kumar K., Kaur G., and Anand S. l-Asparaginase: a promising chemotherapeutic agent. Crit. Rev. Biotechnol. 27 (2007) 45-62
35. Vina L., Karsakevich A., and Bekers M. Stabilization of anti-leukemic enzyme l-asparaginase by immobilization on polysaccharide levan. J. Mol. Catal. B: Enzymatic 11 (2001) 551-558
36. Wileman T.E., Foster R.L., and Elliott P.N.C. Soluble l-asparaginase-dextran conjugates show increased circulatory persistence and lowered antigen reactivity. J. Pharm. Pharmacol. 35 (1983) 762
37. Zhang N., Clarke F., Trapani G.D., Keough D., and Beacham I. Guina pig serum l-asparaginase: purification, and immunological relationship to liver l-asparaginase and serum l-asparaginase in other mammals. Comp. Biochem. Phys. part B: Biochem. Mol. Biol. 112 (1995) 607-612
38. Zhang Y.Q., Tao M.L., Shen W.D., Zhou Y.Z., Ding Y., Ma Y., and Zhou W.L. Immobilization of l-asparaginase on the microparticles of the natural silk sericin protein and its characters. Biomaterials 25 (2004) 3751-4375
39. Zhang Y.Q., Zhou W.L., Shen W.D., Chen Y.H., Zha X.M., Shirai K., and Kiguchi K. Synthesis, characterization and immunogenicity of silk-fibroin-l-asparaginase bioconjugates. J. Biotech. 120 (2005) 315-326